Cargando…

Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis

BACKGROUND: There is a need for a brain volume measure applicable to the clinical routine scans. Nearly every multiple sclerosis (MS) protocol includes low-resolution 2D T2-FLAIR imaging. OBJECTIVES: To develop and validate cross-sectional and longitudinal brain atrophy measures on clinical-quality...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dwyer, Michael G., Silva, Diego, Bergsland, Niels, Horakova, Dana, Ramasamy, Deepa, Durfee, Jaqueline, Vaneckova, Manuela, Havrdova, Eva, Zivadinov, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496213/ https://www.ncbi.nlm.nih.gov/pubmed/28706852 http://dx.doi.org/10.1016/j.nicl.2017.06.022

Ejemplares similares

Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study
por: Barnett, Michael, et al.
Publicado: (2021)

Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study
por: Zivadinov, Robert, et al.
Publicado: (2013)

Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study
por: Bergsland, Niels, et al.
Publicado: (2017)

MRI correlates of disability progression in patients with CIS over 48 months
por: Uher, Tomas, et al.
Publicado: (2014)

Quantifying disease pathology and predicting disease progression in multiple sclerosis with only clinical routine T2-FLAIR MRI
por: Fuchs, Tom A., et al.
Publicado: (2021)

Clinical feasibility of longitudinal lateral ventricular volume measurements on T2-FLAIR across MRI scanner changes
por: Jakimovski, Dejan, et al.
Publicado: (2021)

Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis
por: Uher, Tomas, et al.
Publicado: (2021)

Improved operator agreement and efficiency using the minimum area contour change method for delineation of hyperintense multiple sclerosis lesions on FLAIR MRI
por: Wack, David S, et al.
Publicado: (2013)

Establishing pathological cut-offs for lateral ventricular volume expansion rates
por: Dwyer, Michael G., et al.
Publicado: (2018)

DeepGRAI (Deep Gray Rating via Artificial Intelligence): Fast, feasible, and clinically relevant thalamic atrophy measurement on clinical quality T2-FLAIR MRI in multiple sclerosis
por: Dwyer, Michael, et al.
Publicado: (2021)

Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2019)

Effect of Treatment with Interferon Beta-1a on Changes in Voxel-Wise Magnetization Transfer Ratio in Normal Appearing Brain Tissue and Lesions of Patients with Relapsing–Remitting Multiple Sclerosis: A 24-Week, Controlled Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2014)

Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite MS
por: Zivadinov, Robert, et al.
Publicado: (2020)

Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS
por: Tao, Yazhong, et al.
Publicado: (2015)

Measuring Aqueduct of Sylvius Cerebrospinal Fluid Flow in Multiple Sclerosis Using Different Software
por: Laganà, Maria Marcella, et al.
Publicado: (2021)

Serum Neurofilament Light Chain Levels are Associated with Lower Thalamic Perfusion in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Longitudinal analysis of cerebral aqueduct flow measures: multiple sclerosis flow changes driven by brain atrophy
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Monitoring of radiologic disease activity by serum neurofilaments in MS
por: Uher, Tomas, et al.
Publicado: (2020)

Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial
por: Dwyer, Michael G., et al.
Publicado: (2015)

Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study
por: Horakova, Dana, et al.
Publicado: (2013)

Improved assessment of multiple sclerosis lesion segmentation agreement via detection and outline error estimates
por: Wack, David S, et al.
Publicado: (2012)

Comparison of Standard 1.5 T vs. 3 T Optimized Protocols in Patients Treated with Glatiramer Acetate. A Serial MRI Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2012)

Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study
por: Kalincik, Tomas, et al.
Publicado: (2012)

Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis
por: Ganapathy Subramanian, Ranjani, et al.
Publicado: (2021)

Humoral response to EBV is associated with cortical atrophy and lesion burden in patients with MS
por: Zivadinov, Robert, et al.
Publicado: (2016)

Utility of coronal contrast-enhanced fat-suppressed FLAIR in the evaluation of optic neuropathy and atrophy
por: Boegel, Kevin H., et al.
Publicado: (2017)

Solar flair.
por: Manuel, John S
Publicado: (2003)

Brain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study
por: Jacobsen, Cecilie, et al.
Publicado: (2020)

Reliable measurements of brain atrophy in individual patients with multiple sclerosis
por: Smeets, Dirk, et al.
Publicado: (2016)

Cortical and Deep Gray Matter Perfusion Associations With Physical and Cognitive Performance in Multiple Sclerosis Patients
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Feasibility of detecting atrophy relevant for disability and cognition in multiple sclerosis using 3D-FLAIR
por: Noteboom, Samantha, et al.
Publicado: (2023)

Examining the identification of age-related atrophy between T1 and T1 + T2-FLAIR cortical thickness measurements
por: Lindroth, Heidi, et al.
Publicado: (2019)

Oxidative Stress Markers in Cerebrospinal Fluid of Newly Diagnosed Multiple Sclerosis Patients and Their Link to Iron Deposition and Atrophy
por: Burgetova, Andrea, et al.
Publicado: (2022)

Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: A 10-year follow-up study
por: Jacobsen, Cecilie, et al.
Publicado: (2021)

Comparison between 3D SPACE FLAIR and 3D TSE FLAIR in Menière’s disease
por: Bernaerts, Anja, et al.
Publicado: (2022)

Relationships Among Circulating Levels of Hemostasis Inhibitors, Chemokines, Adhesion Molecules, and MRI Characteristics in Multiple Sclerosis
por: Ziliotto, Nicole, et al.
Publicado: (2020)

Retinal Blood Vessel Analysis Using Optical Coherence Tomography (OCT) in Multiple Sclerosis
por: Young, Nicholas, et al.
Publicado: (2023)

The Effect of Three Times a Week Glatiramer Acetate on Cerebral T1 Hypointense Lesions in Relapsing‐Remitting Multiple Sclerosis
por: Zivadinov, Robert, et al.
Publicado: (2015)

FLAIR-only joint volumetric analysis of brain lesions and atrophy in clinically isolated syndrome (CIS) suggestive of multiple sclerosis
por: Goodkin, O., et al.
Publicado: (2020)

Cognitive clinico‐radiological paradox in early stages of multiple sclerosis
por: Uher, Tomas, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ivql4kr51c2stp60ba051u0spv